Parametric Time‐to‐Event Model for Acute Exacerbations in Idiopathic Pulmonary Fibrosis
We describe a parametric time‐to‐event model for idiopathic pulmonary fibrosis (IPF) exacerbations and identify predictors of exacerbation risk using data obtained for the tyrosine‐kinase inhibitor nintedanib in two phase III studies (INPULSIS‐1/2). Parametric survival analysis was performed on time...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-02-01
|
Series: | CPT: Pharmacometrics & Systems Pharmacology |
Online Access: | https://doi.org/10.1002/psp4.12485 |
id |
doaj-dc0a8deb55fd4386b42f8aeaef39bd7a |
---|---|
record_format |
Article |
spelling |
doaj-dc0a8deb55fd4386b42f8aeaef39bd7a2020-11-25T01:29:41ZengWileyCPT: Pharmacometrics & Systems Pharmacology2163-83062020-02-0192879510.1002/psp4.12485Parametric Time‐to‐Event Model for Acute Exacerbations in Idiopathic Pulmonary FibrosisFei Tang0Benjamin Weber1Susanne Stowasser2Julia Korell3Translational Medicine and Clinical Pharmacology Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield Connecticut USATranslational Medicine and Clinical Pharmacology Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield Connecticut USABoehringer Ingelheim International GmbH Ingelheim am Rhein GermanyTranslational Medicine and Clinical Pharmacology Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield Connecticut USAWe describe a parametric time‐to‐event model for idiopathic pulmonary fibrosis (IPF) exacerbations and identify predictors of exacerbation risk using data obtained for the tyrosine‐kinase inhibitor nintedanib in two phase III studies (INPULSIS‐1/2). Parametric survival analysis was performed on time to first exacerbation (censoring on day 372), with univariate analysis to select statistically significant covariates (P = 0.05). Multivariate covariate models were developed using stepwise covariate modeling with forward inclusion (P = 0.05) and backward elimination (P = 0.01). Sixty‐three first exacerbation events were reported across 1,061 subjects in the INPULSIS studies. Baseline and decline of forced vital capacity (FVC)/percent‐predicted FVC (%pFVC), supplemental oxygen use, baseline CO diffusing capacity and age were statistically significant in the univariate analysis. The final covariate model included decline in FVC to week 52, baseline %pFVC, supplemental oxygen use, and age. The developed model may be used to identify patients at high risk of IPF exacerbations and accelerate development of novel treatments.https://doi.org/10.1002/psp4.12485 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Fei Tang Benjamin Weber Susanne Stowasser Julia Korell |
spellingShingle |
Fei Tang Benjamin Weber Susanne Stowasser Julia Korell Parametric Time‐to‐Event Model for Acute Exacerbations in Idiopathic Pulmonary Fibrosis CPT: Pharmacometrics & Systems Pharmacology |
author_facet |
Fei Tang Benjamin Weber Susanne Stowasser Julia Korell |
author_sort |
Fei Tang |
title |
Parametric Time‐to‐Event Model for Acute Exacerbations in Idiopathic Pulmonary Fibrosis |
title_short |
Parametric Time‐to‐Event Model for Acute Exacerbations in Idiopathic Pulmonary Fibrosis |
title_full |
Parametric Time‐to‐Event Model for Acute Exacerbations in Idiopathic Pulmonary Fibrosis |
title_fullStr |
Parametric Time‐to‐Event Model for Acute Exacerbations in Idiopathic Pulmonary Fibrosis |
title_full_unstemmed |
Parametric Time‐to‐Event Model for Acute Exacerbations in Idiopathic Pulmonary Fibrosis |
title_sort |
parametric time‐to‐event model for acute exacerbations in idiopathic pulmonary fibrosis |
publisher |
Wiley |
series |
CPT: Pharmacometrics & Systems Pharmacology |
issn |
2163-8306 |
publishDate |
2020-02-01 |
description |
We describe a parametric time‐to‐event model for idiopathic pulmonary fibrosis (IPF) exacerbations and identify predictors of exacerbation risk using data obtained for the tyrosine‐kinase inhibitor nintedanib in two phase III studies (INPULSIS‐1/2). Parametric survival analysis was performed on time to first exacerbation (censoring on day 372), with univariate analysis to select statistically significant covariates (P = 0.05). Multivariate covariate models were developed using stepwise covariate modeling with forward inclusion (P = 0.05) and backward elimination (P = 0.01). Sixty‐three first exacerbation events were reported across 1,061 subjects in the INPULSIS studies. Baseline and decline of forced vital capacity (FVC)/percent‐predicted FVC (%pFVC), supplemental oxygen use, baseline CO diffusing capacity and age were statistically significant in the univariate analysis. The final covariate model included decline in FVC to week 52, baseline %pFVC, supplemental oxygen use, and age. The developed model may be used to identify patients at high risk of IPF exacerbations and accelerate development of novel treatments. |
url |
https://doi.org/10.1002/psp4.12485 |
work_keys_str_mv |
AT feitang parametrictimetoeventmodelforacuteexacerbationsinidiopathicpulmonaryfibrosis AT benjaminweber parametrictimetoeventmodelforacuteexacerbationsinidiopathicpulmonaryfibrosis AT susannestowasser parametrictimetoeventmodelforacuteexacerbationsinidiopathicpulmonaryfibrosis AT juliakorell parametrictimetoeventmodelforacuteexacerbationsinidiopathicpulmonaryfibrosis |
_version_ |
1725095468888752128 |